• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Zestril (lisinopril) tablet

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2009

 

Summary View

 

ADVERSE REACTIONS

Endocrine
  • the term, “inappropriate antidiuretic hormone section” was added after, “diabetes mellitus.”
  • the term, “olfactory disturbance” was added after, “taste disturbances.”